What are neuroendocrine tumors, and how are they treated? MD Anderson Cancer Center - 23 Feb 2024 What are neuroendocrine tumors, and how are they treated? ... More
Lutathera Delays Growth of Advanced Neuroendocrine Tumors National Cancer Institute (.gov) - 01 Mar 2024 Lutathera Delays Growth of Advanced Neuroendocrine Tumors ... More
FDA Approves Lutathera for Pediatric Patients With SSTR+ Gastroenteropancreatic Neuroendocrine Tumors Pharmacy Times - 23 Apr 2024 FDA Approves Lutathera for Pediatric Patients With SSTR+ Gastroenteropancreatic Neuroendocrine Tumors ... More
Traction Devices May Not Affect the Vertical Margin Distance in the Endoscopic Submucosal Dissection of Rectal ... Cureus - 25 Apr 2024 Traction Devices May Not Affect the Vertical Margin Distance in the Endoscopic Submucosal Dissection of Rectal ... ... More
What Are Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)? Everyday Health - 09 Apr 2024 What Are Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)? ... More
Neuroendocrine Tumors: The Zebra of Cancers - InventUM University of Miami - 11 Oct 2023 Neuroendocrine Tumors: The Zebra of Cancers - InventUM ... More
Lutathera Approved for Pediatric Patients 12 Years and Older With GEP-NETS Pharmacy Practice News - 23 Apr 2024 Lutathera Approved for Pediatric Patients 12 Years and Older With GEP-NETS ... More
FDA Approves Lutetium Lu 177 Dotatate for Pediatric SSTR+ GEP-NETs OncLive - 23 Apr 2024 FDA Approves Lutetium Lu 177 Dotatate for Pediatric SSTR+ GEP-NETs ... More
Unraveling the impact of cancer-associated fibroblasts on hypovascular pancreatic neuroendocrine tumors | British ... Nature.com - 10 Feb 2024 Unraveling the impact of cancer-associated fibroblasts on hypovascular pancreatic neuroendocrine tumors | British ... ... More
Study findings better define the genetic landscape of neuroendocrine tumors of the cervix News-Medical.Net - 17 Apr 2024 Study findings better define the genetic landscape of neuroendocrine tumors of the cervix ... More
FDA Approves First Radioactive Drug for Children With SSTR-Positive GEP-NETs www.oncnursingnews.com/ - 23 Apr 2024 FDA Approves First Radioactive Drug for Children With SSTR-Positive GEP-NETs ... More
Management of type 1 gastric neuroendocrine tumors: an 11-year retrospective single-center study - BMC ... BMC Gastroenterology - 14 Dec 2023 Management of type 1 gastric neuroendocrine tumors: an 11-year retrospective single-center study - BMC ... ... More
Neuroendocrine Tumor Treatment Market revenue to hit USD 8 Billion by 2035, says Research Nester Yahoo Finance - 12 Mar 2024 Neuroendocrine Tumor Treatment Market revenue to hit USD 8 Billion by 2035, says Research Nester ... More
Lutathera Approved for Pediatric Patients 12 Years and Older With GEP-NETS Clinical Oncology News - 24 Apr 2024 Lutathera Approved for Pediatric Patients 12 Years and Older With GEP-NETS ... More
Intertumoral lineage diversity and immunosuppressive transcriptional programs in well-differentiated ... Science - 27 Sep 2023 Intertumoral lineage diversity and immunosuppressive transcriptional programs in well-differentiated ... ... More
NET Tumor Conference to Advance Understanding of Complex, Rare Cancers - InventUM University of Miami - 28 Mar 2024 NET Tumor Conference to Advance Understanding of Complex, Rare Cancers - InventUM ... More
C1QA and COMP: plasma-based biomarkers for early diagnosis of pancreatic neuroendocrine tumors | Scientific Reports Nature.com - 29 Nov 2023 C1QA and COMP: plasma-based biomarkers for early diagnosis of pancreatic neuroendocrine tumors | Scientific Reports ... More
Case series of ovarian neuroendocrine carcinoma: overview of clinicopathological features - BMC Women's Health BioMed Central - 13 Nov 2023 Case series of ovarian neuroendocrine carcinoma: overview of clinicopathological features - BMC Women's Health ... More
Long-term outcomes of endoscopic resection for duodenal neuroendocrine tumors | Scientific Reports Nature.com - 20 Oct 2023 Long-term outcomes of endoscopic resection for duodenal neuroendocrine tumors | Scientific Reports ... More